← All trials
NCT04756726
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 27, 2021
- Primary completion
- Sep 7, 2024
- Completion date
- Dec 7, 2024
- First posted
- Feb 16, 2021
- Last posted
- Aug 17, 2021
- Enrollment
- 158
- Arms / groups
- 8 / —
- Source
- AACT · ingestion pipeline
Sponsors
- C4 Therapeutics, Inc.Lead sponsor
- C4 Therapeutics, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.